Dopamine release in the nucleus accumbens: The perspective from aberrations of consciousness in schizophrenia

Studies of the cognitive abnormalities that underlie positive symptoms in acute schizophrenia, and animal experiments that attempt to model similar cognitive abnormalities and to elucidate the brain mechanisms underlying them, suggest that the release of dopamine from A 10 terminals in the nucleus (n.) accumbens, in interaction with the projection to n. accumbens from the retrohippocampal region, is closely related to stimulus salience and perhaps to the heightened states of awareness reported by schizophrenics.

[1]  H. Hodges,et al.  The effects of ritanserin, RU 24969 and 8-OH-DPAT on latent inhibition in the rat , 1993, Journal of psychopharmacology.

[2]  N. Gray.  Abolition of latent inhibition in acute, but not chronic, schizophrenics , 1992 .

[3]  J. Gray,et al.  5,7-Dihydroxytryptamine lesions in the fornix-fimbria attenuate latent inhibition. , 1993, Behavioral and neural biology.

[4]  D. Hemsley.  An Experimental Psychological Model for Schizophrenia , 1987 .

[5]  M. Konstandi,et al.  Effects of striatal or accumbens lesions on the amphetamine-induced abolition of latent inhibition , 1993, Pharmacology Biochemistry and Behavior.

[6]  J. Gray,et al.  Contextual Effects on Choice Reaction Time and Accuracy in Acute and Chronic Schizophrenics Impairment in Selective Attention or in the Influence of Prior Learning? , 1991, British Journal of Psychiatry.

[7]  R. Lubow,et al.  The effects of preexposure to a nonattended stimulus on subsequent learning: Latent inhibition in adults. , 1975 .

[8]  R. Lubow.  Latent Inhibition and Conditioned Attention Theory , 1989 .

[9]  S. Pr,et al.  Differential effects of microinjections of d-amphetamine into the nucleus accumbens or the caudate putamen on the rat's ability to ignore an irrelevant stimulus. , 1982 .

[10]  A. D. Smith,et al.  Convergence of hippocampal and dopaminergic input onto identified neurons in the nucleus accumbens of the rat. , 1989, Journal of chemical neuroanatomy.

[11]  O. Lipp,et al.  Latent inhibition in human Pavlovian differential conditioning: Effect of additional stimulation after preexposure and relation to schizotypal traits☆ , 1992 .

[12]  J. Rawlins,et al.  Distribution of Latent Inhibition By Interupting the Subicular Input To Nucleus Accumbens and Its Antagonism By Haloperidol , 1992, Journal of psychopharmacology.

[13]  R. Lubow,et al.  Latent inhibition and recall/recognition of irrelevant stimuli as a function of pre-exposure duration in high and low psychotic-prone normal subjects. , 1993, British journal of psychology.

[14]  A. Dickinson.  Contemporary Animal Learning Theory , 1981 .

[15]  Gregory Bock,et al.  Experimental and theoretical studies of consciousness , 1993 .

[16]  I. Weiner,et al.  The latent inhibition model of schizophrenic attention disorder Haloperidol and sulpiride enhance rats' ability to ignore irrelevant stimuli , 1991, Biological Psychiatry.

[17]  N. Swerdlow,et al.  Dopamine, schizophrenia, mania, and depression: Toward a unified hypothesis of cortico-striatopallido-thalamic function , 1987, Behavioral and Brain Sciences.

[18]  J. Rawlins,et al.  Both Electrolytic and Excitotoxic Lesions of Nucleus Accumbens Disrupt Latent Inhibition of Learning in Rats , 1995, Neurobiology of Learning and Memory.

[19]  J. Rawlins,et al.  The neuropsychology of schizophrenia , 1991, Behavioral and Brain Sciences.

[20]  R. Lubow,et al.  Chronic amphetamine and latent inhibition , 1981, Behavioural Brain Research.

[21]  M. Velmans.  Is human information processing conscious? , 1991, Behavioral and Brain Sciences.

[22]  J. Gray,et al.  Latent inhibition in drug naive schizophrenics: relationship to duration of illness and dopamine D2 binding using SPET , 1995, Schizophrenia Research.

[23]  L. Sokoloff,et al.  Correlation of dose-dependent effects of acute amphetamine administration on behavior and local cerebral metabolism in rats , 1984, Brain Research.

[24]  R. Lubow,et al.  Latent inhibition in low and high "psychotic-prone" normal subjects. , 1992 .

[25]  B. Freedman.  The subjective experience of perceptual and cognitive disturbances in schizophrenia. A review of autobiographical accounts. , 1974, Archives of general psychiatry.

[26]  J. Gray,et al.  Latent inhibition of conditioned dopamine release in rat nucleus accumbens , 1993, Neuroscience.

[27]  J. Gray,et al.  The contents of consciousness: A neuropsychological conjecture , 1995, Behavioral and Brain Sciences.

[28]  R. Hinde,et al.  Short-Term Changes in Neural Activity and Behaviour , 1972 .

[29]  Joseph Mh,et al.  Haloperidol potentiation of latent inhibition in rats: evidence for a critical role at conditioning rather than pre-exposure. , 1993 .

[30]  J. Gray,et al.  Latent inhibition and “psychotic proneness” in normal subjects , 1988 .

[31]  T. Crow.  Positive and Negative Schizophrenic Symptoms and the Role of Dopamine , 1980, British Journal of Psychiatry.

[32]  P. Solomon,et al.  Disrupted latent inhibition in the rat with chronic amphetamine or haloperidol-induced supersensitivity: relationship to schizophrenic attention disorder. , 1981, Biological psychiatry.

[33]  W. Gattaz,et al.  Search for the Causes of Schizophrenia , 1987, Springer Berlin Heidelberg.

[34]  J. Gray,et al.  Differential Performance of Acute and Chronic Schizophrenics in a Latent Inhibition Task , 1988, The Journal of nervous and mental disease.

[35]  J. Rawlins,et al.  Aspiration lesions of rat ventral hippocampus disinhibit responding in conditioned suppression or extinction, but spare latent inhibition and the partial reinforcement extinction effect , 1992, Neuroscience.

[36]  J. Gray,et al.  Précis of The neuropsychology of anxiety: An enquiry into the functions of the septo-hippocampal system , 1982, Behavioral and Brain Sciences.

[37]  R. Lubow,et al.  Latent inhibition: the effect of nonreinforced pre-exposure to the conditional stimulus. , 1959, Journal of comparative and physiological psychology.

[38]  J. Gray,et al.  Acute administration of nicotine increases the in vivo extracellular levels of dopamine, 3,4-dihydroxyphenylacetic acid and ascorbic acid preferentially in the nucleus accumbens of the rat: Comparison with caudate-putamen , 1990, Neuropharmacology.

[39]  J. Rawlins,et al.  Schiz bits: Misses, mysteries and hits , 1991, Behavioral and Brain Sciences.

[40]  J. Rawlins,et al.  Latent inhibition in rats is abolished by NMDA-induced neuronal loss in the retrohippocampal region, but this lesion effect can be prevented by systemic haloperidol treatment. , 1995, Behavioral neuroscience.

[41]  D. Hemsley.  A simple (or simplistic?) cognitive model for schizophrenia. , 1993, Behaviour research and therapy.

[42]  J. Gray,et al.  Consciousness, schizophrenia and scientific theory. , 2007, Ciba Foundation symposium.